1) Bouscaillou J, Komas N, Tricou V, Nakouné E, Sélékon B, Fontanet A, Kazanji M. Imported hepatitis E virus, central African Republic, 2011. Emerg Infect Dis. 2013 Feb;19(2):325-7. Abstract

2) Rentsch CA, Biot C, Gsponer JR, Bachmann A, Albert ML, Breban R. BCG-Mediated Bladder Cancer Immunotherapy:Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model. PLoS One. 2013;8(2):e56327. Abstract

3) Garenne M, Kahn K, Collinson M, Gómez-Olivé X, Tollman S. Protective effect of pregnancy in rural South Africa: questioning the concept of "indirect cause" of maternal death. PLoS One. 2013 May 13;8(5):e64414. Abstract

4) Williams J, Ibisomi L, Sartorius B, Kahn K, Collinson M, Tollman S, Garenne M. Convergence in fertility of South Africans and Mozambicans in rural South Africa, 1993-2009. Glob Health Action. 2013 Jan 24;6:19236. Abstract

5) Mueller JE. Conjugate vaccine introduction in the African meningitis belt : meeting surveillance objectives. Trop Med Int Health. 2013 Jan ;18(1) :58-64. Abstract

6) Munier A, Marzouk D, Abravanel F, El-Daly M, Taylor S, Mamdouh R, Eldin WS, El-Arab HE, Sos DG, Momen M, Okasha O, Le Fouler L, El-Hosini M, Izopet J, Rafik M, Albert M, Abdel-Hamid M, Mohamed MK, Delarocque-Astagneau E, Fontanet A. Frequent Transient Hepatitis C viremia without seroconversion among Healthcare Workers in Cairo, Egypt. PLoS One. 2013;8(2):e57835. Abstract

7) Breban R. Role of environmental persistence in pathogen transmission: a mathematical modeling approach. J Math Biol. 2013 Feb;66(3):535-46. Abstract

8) Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat. 2013 Apr;20(4):294-6. Abstract

9) Garenne M, Maire B, Fontaine O, Briend A. Adequacy of child anthropometric indicators for measuring nutritional stress at population level: a study from Niakhar, Senegal. Public Health Nutr. 2013 Sep;16(9):1533-9. Abstract

10) Borand L, Laureillard D, Madec Y, Chou M, Pheng P, Marcy O, Sok T, Goldfeld AE, Taburet AM, Blanc FX; the CAMELIA (ANRS 1295-CIPRA KH001) study team. Plasma concentrations of efavirenz with a 600 mg standard dose in Cambodia HIV-infected adults treated for tuberculosis with a body weight above 50 kg. Antivir Ther. 2013;18(3):419-23. Abstract 11) Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A. Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study. PLoS Negl Trop Dis. 2013;7(3):e2137. Abstract

12) Madec Y, Boufassa F, Porter K, Prins M, Sabin C, Monforte AD, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L. Natural history of HIV-control since seroconversion. AIDS. 2013 Sep 24;27(15):2451-2460. Abstract

13) Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O. ALA Study Group. Imported amoebic liver abscess in france. PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2333. Abstract

14) Nouhin J, Madec Y, Ngo-Giang-Huong N, Ferradini L, Nerrienet E. Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia. PLoS One. 2013 Aug 28;8(8):e73744. Abstract

15) Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Rekacewicz C, Prak N, Kim C, Sath S, Hak C, Dim B, Nerrienet E, Fox L, Sok T, Delfraissy J-F, Goldfeld AE, Blanc F-X for the CAMELIA (ANRS 1295 – CIPRA KH001) Study Team. Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome After Early Initiation of Antiretroviral Therapy in the CAMELIA Randomized Trial. AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01. aids.0000432456.14099.c7.  PubMed PMID:24096631. Abstract

16) Thibault V, Laperche S, Thiers V, Sayon S, Letort MJ, Delarocque-Astagneau E, Antona D. Molecular epidemiology and clinical characteristics of Hepatitis B identified through the French Mandatory Notification System. PLoS One. 2013 Sep 25;8(9):e75267. Abstract

17) Stamenkovic S, Solesse A, Zanetti L, Zagury P, Vray M; le groupe Intérêt de santé publique et études post-inscription (ISPEP). [French Health Authority (HAS) Guidance: the post-registration studies on health technologies (drugs, medical devices and instruments): principles and methods]. Therapie. 2012 Sep-Oct;67(5):409-21. Abstract

18) Bourhy P, Vray M, Picardeau M. Evaluation of an in-house ELISA using the intermediate species Leptospira fainei for diagnosis of leptospirosis. J Med Microbiol. 2013 Jun;62(Pt 6):822-7. Abstract 19) Morizot G, Kendjo E, Mouri O, Thellier M, Pérignon A, Foulet F, Cordoliani F, Bourrat E, Laffitte E, Alcaraz I, Bodak N, Ravel C, Vray M, Grogl M, Mazier D, Caumes E, Lachaud L, Buffet PA; Cutaneous Leishmaniasis French Study Group. Travelers with cutaneous leishmaniasis cured without systemic therapy. Clin Infect Dis. 2013 Aug;57(3):370-80. Abstract

20) Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization. Pediatr Infect Dis J. 2013 Oct;32(10):1110-1115. Abstract

21) Sire JM, Garin B, Chartier L, Fall NK, Tall A, Seck A, Weill FX, Breurec S, Vray M. Community-acquired infectious diarrhoea in children under 5 years of age in Dakar, Senegal. Paediatr Int Child Health. 2013;33(3):139-44. Abstract

22) Manirakiza A, Sepou A, Serdouma E, Gondje S, Bata GG, Moussa S, Boulay A, Moyen JM, Sakanga O, Le Fouler L, Kazanji M, Vray M. Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA). Trials. 2013 Aug 14;14(1):255. Abstract

23) Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F. Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection.  J Clin Virol. 2013 Oct;58(2):461-7. doi: 10.1016/j.jcv.2013.08.003. Epub 2013 Aug 14. PubMed PMID:24008204. Abstract

24) Allouch A, David A, Amie SM, Lahouassa H, Chartier L, Margottin-Goguet F, Barré-Sinoussi F, Kim B, Sáez-Cirión A, Pancino G. p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway. Proc Natl Acad Sci U S A. 2013 Sep 30. Abstract

25) Ragab D, Laird M, Duffy D, Casrouge A, Mamdouh R, Abass A, Shenawy DE, Shebl AM, Elkashef WF, Zalata KR, Kamal M, Esmat G, Bonnard P, Fontanet A, Rafik M, Albert ML. CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients. Cytokine. 2013 Aug;63(2):105-12. doi: 10.1016/ j.cyto.2013.04.016. Epub 2013 May 7. Erratum in: Cytokine. 2014 Jan;65(1):119-20. PubMed PMID: 23664274.. Abstract

26) Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S; MERS-CoV study group. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29;381(9885):2265-72. Abstract

27) Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middel East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet. 2013 Aug 24;382(9893):694-9. Abstract

28) Herrant M, Loucoubar C, Bassène H, Gonçalves B, Boufkhed S, Diene Sarr F, Fontanet A, Tall A, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R. Asthma and atopic dermatitis are associated with increased risk of clinical Plasmodium falciparum malaria. BMJ Open. 2013 Jul 24;3(7). pii: e002835. doi: 10.1136/bmjopen-2013-002835. Print 2013. PubMed PMID: 23883878; PubMed Central PMCID: PMC3731724. Abstract

29) Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK. Quantifying current hepatitis C virus incidence in Egypt – Response to letter by Miller and Abu-Raddad. J Viral Hepat. 2013 Sep;20(9):668. Abstract

30) Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol. 2013 Oct 1. Abstract

31) Matthews AP, Garenne M. A dynamic model of the marriage market-Part 1: Matching algorithm based on age preference and availability. Theor Popul Biol. 2013 Jan 25. Abstract 

32) Matthews AP, Garenne ML. A dynamic model of the marriage market-Part 2: Simulation of marital states and application to empirical data. Theor Popul Biol. 2013 Sep;88:86-93. Abstract

33) Garenne M, Kahn K, Collinson MA, Gómez-Olivé FX, Tollman S. Maternal mortality in rural South Africa: the impact of case definition on levels and trends. Int J Womens Health. 2013;5:457-63. Abstract

34) Xie O, Pollard AJ, Mueller JE, Norheim G. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine. Vaccine. 2013 Jun 12;31(27):2852-61. Abstract

35) Madec Y, Leroy S, Rey-Cuille MA, Huber F, Calmy A. Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa-A Systematic Review and Meta-Analysis. PLoS One.2013 Dec 23;8(12):e82724. doi:10.1371 /journal.pone.0082724. PubMed PMID: 24376570; PubMed Central PMCID:PMC3871158. Abstract

36) Heard I, Tondeur L, Arowas L, Falguières M, Demazoin MC, Favre M. Human papillomavirus types distribution in organised cervical cancer screening in France. PLoS One. 2013 Nov 14;8(11):e79372. doi: 10.1371/journal.pone.0079372. PubMed PMID: 24244490; PubMed Central PMCID: PMC3828354. Abstract

37) Marion E, Landier J, Eyangoh S, Marsollier L. Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes. Med Sci (Paris). 2013 Oct;29(10):912-7. doi: 10.1051/medsci/20132910021. Epub 2013 Oct 18. French. PubMed PMID: 24148132. Abstract

Mis à jour le 17/06/2014


Unité d'Epidémiologie des Maladies Emergentes

Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15

Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 76

Où nous trouver ?